Kodiak Sciences Stock Cash Flow From Operations
| KOD Stock | USD 5.90 0.11 1.90% |
Kodiak Sciences fundamentals help investors to digest information that contributes to Kodiak Sciences' financial success or failures. It also enables traders to predict the movement of Kodiak Stock. The fundamental analysis module provides a way to measure Kodiak Sciences' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kodiak Sciences stock.
Kodiak |
Kodiak Sciences Company Cash Flow From Operations Analysis
Kodiak Sciences' Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
Current Kodiak Sciences Cash Flow From Operations | (154.18 M) |
Most of Kodiak Sciences' fundamental indicators, such as Cash Flow From Operations, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kodiak Sciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
| Competition |
In accordance with the recently published financial statements, Kodiak Sciences has (154.18 Million) in Cash Flow From Operations. This is 129.24% lower than that of the Biotechnology sector and significantly lower than that of the Health Care industry. The cash flow from operations for all United States stocks is 115.88% higher than that of the company.
Kodiak Cash Flow From Operations Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kodiak Sciences' direct or indirect competition against its Cash Flow From Operations to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kodiak Sciences could also be used in its relative valuation, which is a method of valuing Kodiak Sciences by comparing valuation metrics of similar companies.Kodiak Sciences is currently under evaluation in cash flow from operations category among its peers.
Kodiak Fundamentals
| Return On Equity | -0.71 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 180.26 M | ||||
| Shares Outstanding | 52.62 M | ||||
| Shares Owned By Insiders | 5.65 % | ||||
| Shares Owned By Institutions | 77.79 % | ||||
| Number Of Shares Shorted | 1.3 M | ||||
| Price To Earning | (2.29) X | ||||
| Price To Book | 1.64 X | ||||
| EBITDA | (259.02 M) | ||||
| Net Income | (260.49 M) | ||||
| Cash And Equivalents | 597.88 M | ||||
| Cash Per Share | 11.55 X | ||||
| Total Debt | 81.63 M | ||||
| Debt To Equity | 0.16 % | ||||
| Current Ratio | 8.65 X | ||||
| Book Value Per Share | 5.08 X | ||||
| Cash Flow From Operations | (154.18 M) | ||||
| Short Ratio | 5.19 X | ||||
| Earnings Per Share | (3.64) X | ||||
| Price To Earnings To Growth | (0.08) X | ||||
| Target Price | 4.33 | ||||
| Number Of Employees | 111 | ||||
| Beta | 2.25 | ||||
| Market Capitalization | 304.69 M | ||||
| Total Asset | 479.37 M | ||||
| Retained Earnings | (1.15 B) | ||||
| Working Capital | 247.58 M | ||||
| Current Asset | 7.31 M | ||||
| Current Liabilities | 4.89 M | ||||
| Net Asset | 479.37 M |
About Kodiak Sciences Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kodiak Sciences's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kodiak Sciences using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kodiak Sciences based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kodiak Sciences is a strong investment it is important to analyze Kodiak Sciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Kodiak Sciences' future performance. For an informed investment choice regarding Kodiak Stock, refer to the following important reports:Check out Kodiak Sciences Piotroski F Score and Kodiak Sciences Altman Z Score analysis. For information on how to trade Kodiak Stock refer to our How to Trade Kodiak Stock guide.You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kodiak Sciences. If investors know Kodiak will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kodiak Sciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Kodiak Sciences is measured differently than its book value, which is the value of Kodiak that is recorded on the company's balance sheet. Investors also form their own opinion of Kodiak Sciences' value that differs from its market value or its book value, called intrinsic value, which is Kodiak Sciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kodiak Sciences' market value can be influenced by many factors that don't directly affect Kodiak Sciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kodiak Sciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kodiak Sciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kodiak Sciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.